US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Jun 12, 2024 (2 years ago)

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C

What was recalled

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32 mg per vial, Rx only, Manufactured for: Pacira Pharmaceuticals Inc., San Diego, CA 92121, NDC 65250-003-01 (carton) NDC 65250-001-01 (vial) with Diluent 5 mL Sterile single-use vial, Rx Only, Mfd. for: Pacira Pharmaceuticals, Inc. NDC 65250-002-01

Recalling firm
Pacira Pharmaceuticals INC
NDC code
65250-003-01
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0567-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Triamcinolone recalls

See all